The clinical-stage biotech could see its shares plummet should there be any clinical setback.

MercadoLibre has multiple growth engines propelling it in 2026. In addition to e-commerce, the company operates in financial ...

In a recent report, remote-work site FlexJobs noted that work-from-home job postings recently increased by 3%, indicating ...

Beyond obvious AI plays like Nvidia, experts see opportunity in shares of infrastructure companies, some of which remain ...

Biotech companies provide the medical innovations and technological breakthroughs that improve healthcare and can achieve ...

Over the past few years, Axsome Therapeutics has made slow and steady clinical and regulatory progress. The company's lineup ...

That morning, Vera announced that its biologics license application (BLA) for its atacicept was accepted for priority review ...

The growing prevalence of chronic diseases like cancer and diabetes is driving increasing innovation in medical device ...

Oppenheimer Research released a list of its best ideas for small-caps and mid-caps in the new year.

JPMorgan has released its latest U.S. Analyst Focus List, highlighting top healthcare investment ideas across growth, income, value, and short strategies. The healthcare sector continues to ...